Cargando…

Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission

Influenza viruses cause seasonal outbreaks and pose a continuous pandemic threat. Although vaccines are available for influenza control, their efficacy varies each season and a vaccine for a novel pandemic virus manufactured using current technology will not be available fast enough to mitigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Leo Yi Yang, Zhou, Jie, Frise, Rebecca, Goldhill, Daniel H., Koszalka, Paulina, Mifsud, Edin J., Baba, Kaoru, Noda, Takahiro, Ando, Yoshinori, Sato, Kenji, Yuki, Aoe-Ishikawa, Shishido, Takao, Uehara, Takeki, Wildum, Steffen, Zwanziger, Elke, Collinson, Neil, Kuhlbusch, Klaus, Clinch, Barry, Hurt, Aeron C., Barclay, Wendy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159184/
https://www.ncbi.nlm.nih.gov/pubmed/32294137
http://dx.doi.org/10.1371/journal.ppat.1008395
_version_ 1783522611129483264
author Lee, Leo Yi Yang
Zhou, Jie
Frise, Rebecca
Goldhill, Daniel H.
Koszalka, Paulina
Mifsud, Edin J.
Baba, Kaoru
Noda, Takahiro
Ando, Yoshinori
Sato, Kenji
Yuki, Aoe-Ishikawa
Shishido, Takao
Uehara, Takeki
Wildum, Steffen
Zwanziger, Elke
Collinson, Neil
Kuhlbusch, Klaus
Clinch, Barry
Hurt, Aeron C.
Barclay, Wendy S.
author_facet Lee, Leo Yi Yang
Zhou, Jie
Frise, Rebecca
Goldhill, Daniel H.
Koszalka, Paulina
Mifsud, Edin J.
Baba, Kaoru
Noda, Takahiro
Ando, Yoshinori
Sato, Kenji
Yuki, Aoe-Ishikawa
Shishido, Takao
Uehara, Takeki
Wildum, Steffen
Zwanziger, Elke
Collinson, Neil
Kuhlbusch, Klaus
Clinch, Barry
Hurt, Aeron C.
Barclay, Wendy S.
author_sort Lee, Leo Yi Yang
collection PubMed
description Influenza viruses cause seasonal outbreaks and pose a continuous pandemic threat. Although vaccines are available for influenza control, their efficacy varies each season and a vaccine for a novel pandemic virus manufactured using current technology will not be available fast enough to mitigate the effect of the first pandemic wave. Antivirals can be effective against many different influenza viruses but have not thus far been used extensively for outbreak control. Baloxavir, a recently licensed antiviral drug that targets the influenza virus endonuclease, has been shown to reduce virus shedding more effectively than oseltamivir, a widely used neuraminidase inhibitor drug. Thus it is possible that treatment with baloxavir might also interrupt onward virus transmission. To test this, we utilized the ferret model, which is the most commonly used animal model to study influenza virus transmission. We established a subcutaneous baloxavir administration method in ferrets which achieved similar pharmacokinetics to the approved human oral dose. Transmission studies were then conducted in two different locations with different experimental setups to compare the onward transmission of A(H1N1)pdm09 virus from infected ferrets treated with baloxavir, oseltamivir or placebo to naïve sentinel ferrets exposed either indirectly in adjacent cages or directly by co-housing. We found that baloxavir treatment reduced infectious viral shedding in the upper respiratory tract of ferrets compared to placebo, and reduced the frequency of transmission amongst sentinels in both experimental setups, even when treatment was delayed until 2 days post-infection. In contrast, oseltamivir treatment did not substantially affect viral shedding or transmission compared to placebo. We did not detect the emergence of baloxavir-resistant variants in treated animals or in untreated sentinels. Our results support the concept that antivirals which decrease viral shedding could also reduce influenza transmission in the community.
format Online
Article
Text
id pubmed-7159184
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71591842020-04-22 Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission Lee, Leo Yi Yang Zhou, Jie Frise, Rebecca Goldhill, Daniel H. Koszalka, Paulina Mifsud, Edin J. Baba, Kaoru Noda, Takahiro Ando, Yoshinori Sato, Kenji Yuki, Aoe-Ishikawa Shishido, Takao Uehara, Takeki Wildum, Steffen Zwanziger, Elke Collinson, Neil Kuhlbusch, Klaus Clinch, Barry Hurt, Aeron C. Barclay, Wendy S. PLoS Pathog Research Article Influenza viruses cause seasonal outbreaks and pose a continuous pandemic threat. Although vaccines are available for influenza control, their efficacy varies each season and a vaccine for a novel pandemic virus manufactured using current technology will not be available fast enough to mitigate the effect of the first pandemic wave. Antivirals can be effective against many different influenza viruses but have not thus far been used extensively for outbreak control. Baloxavir, a recently licensed antiviral drug that targets the influenza virus endonuclease, has been shown to reduce virus shedding more effectively than oseltamivir, a widely used neuraminidase inhibitor drug. Thus it is possible that treatment with baloxavir might also interrupt onward virus transmission. To test this, we utilized the ferret model, which is the most commonly used animal model to study influenza virus transmission. We established a subcutaneous baloxavir administration method in ferrets which achieved similar pharmacokinetics to the approved human oral dose. Transmission studies were then conducted in two different locations with different experimental setups to compare the onward transmission of A(H1N1)pdm09 virus from infected ferrets treated with baloxavir, oseltamivir or placebo to naïve sentinel ferrets exposed either indirectly in adjacent cages or directly by co-housing. We found that baloxavir treatment reduced infectious viral shedding in the upper respiratory tract of ferrets compared to placebo, and reduced the frequency of transmission amongst sentinels in both experimental setups, even when treatment was delayed until 2 days post-infection. In contrast, oseltamivir treatment did not substantially affect viral shedding or transmission compared to placebo. We did not detect the emergence of baloxavir-resistant variants in treated animals or in untreated sentinels. Our results support the concept that antivirals which decrease viral shedding could also reduce influenza transmission in the community. Public Library of Science 2020-04-15 /pmc/articles/PMC7159184/ /pubmed/32294137 http://dx.doi.org/10.1371/journal.ppat.1008395 Text en © 2020 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lee, Leo Yi Yang
Zhou, Jie
Frise, Rebecca
Goldhill, Daniel H.
Koszalka, Paulina
Mifsud, Edin J.
Baba, Kaoru
Noda, Takahiro
Ando, Yoshinori
Sato, Kenji
Yuki, Aoe-Ishikawa
Shishido, Takao
Uehara, Takeki
Wildum, Steffen
Zwanziger, Elke
Collinson, Neil
Kuhlbusch, Klaus
Clinch, Barry
Hurt, Aeron C.
Barclay, Wendy S.
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title_full Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title_fullStr Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title_full_unstemmed Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title_short Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
title_sort baloxavir treatment of ferrets infected with influenza a(h1n1)pdm09 virus reduces onward transmission
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159184/
https://www.ncbi.nlm.nih.gov/pubmed/32294137
http://dx.doi.org/10.1371/journal.ppat.1008395
work_keys_str_mv AT leeleoyiyang baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT zhoujie baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT friserebecca baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT goldhilldanielh baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT koszalkapaulina baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT mifsudedinj baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT babakaoru baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT nodatakahiro baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT andoyoshinori baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT satokenji baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT yukiaoeishikawa baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT shishidotakao baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT ueharatakeki baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT wildumsteffen baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT zwanzigerelke baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT collinsonneil baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT kuhlbuschklaus baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT clinchbarry baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT hurtaeronc baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission
AT barclaywendys baloxavirtreatmentofferretsinfectedwithinfluenzaah1n1pdm09virusreducesonwardtransmission